{
  "id": "8dc7f8209dabbf61",
  "title": "FDA Accepts for Priority Review sBLA for Teplizumab for Children With Stage 2 T1D",
  "description": "20260105T230000Z",
  "content": "",
  "source": "hcplive.com",
  "source_url": "https://www.hcplive.com/view/fda-accepts-for-priority-review-sbla-for-teplizumab-for-children-with-stage-2-t1d",
  "published_at": "20260105T230000Z",
  "fetched_at": "2026-01-06T00:23:36.488656+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.hcplive.com/view/fda-accepts-for-priority-review-sbla-for-teplizumab-for-children-with-stage-2-t1d",
    "url_mobile": "",
    "title": "FDA Accepts for Priority Review sBLA for Teplizumab for Children With Stage 2 T1D",
    "seendate": "20260105T230000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/hcplive/5682e67871db44b3d6974abfb8120d98f72f32a6-1200x1200.heif",
    "domain": "hcplive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}